Kinetic assessment of breast tumors using high spatial resolution signal enhancement ratio (SER) imaging

Magnetic Resonance in Medicine

Volumn 58, Issue 3, 2007, Pages 572-581

  Li, Ka Loh ^a   Henry, Roland G ^a   Wilmes, Lisa J ^a   Gibbs, Jessica ^a   Zhu, Xiaoping ^a   Lu, Ying ^a   Hylton, Nola M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Contrast enhanced MRI; Pharmacokinetic modeling; Signal enhancement ratio (SER)

Indexed keywords

DISEASES; IMAGE RESOLUTION; MAMMALS; PHARMACOKINETICS; PIXELS; RATE CONSTANTS; TISSUE;

BREAST CANCER; CONTRAST-ENHANCED; HIGH TEMPORAL RESOLUTION; MATHEMATICAL RELATIONSHIP; PHARMACOKINETIC MODEL; PHARMACOKINETIC PARAMETERS; SIGNAL ENHANCEMENT; SPEARMAN RANK CORRELATION;

MEDICAL IMAGING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; COMPARTMENT MODEL; COMPUTER SIMULATION; CONTRAST ENHANCEMENT; HUMAN; IN VIVO STUDY; MATHEMATICAL MODEL; MEASUREMENT ERROR; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY;

EID: 36348944702     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21361     Document Type: Article

References (38)

1. Collins DJ, Padhani AR. Dynamic magnetic resonance imaging of tumor perfusion. Approaches and biomedical challenges. IEEE Eng Med Biol Mag 2004;23:65-83.
2. Knopp MV, Brix G, Junkermann HJ, Sinn HP. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Magn Reson Imaging Clin N Am 1994;2:633-658.
3. Tofts P, Berkowitz B, Schnall M. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumours using a permeability model. Mag Res Med 1995;33:564-568.
4. den Boer JA, Hoenderop RK, Smink J, Dornseiffen G, Koch PW, Mulder JH, Slump CH, Volker ED, de Vos RA. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions. J Magn Reson Imaging 1997;7:702-715.
5. Mussurakis S, Buckley DL, Drew PJ, Fox JN, Carleton PJ, Turnbull LW, Horsman A. Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours. Clin Radiol 1997;52:516-526.
6. Issa B, Buckley DL, Turnbull LW. Heterogeneity analysis of Gd-DTPA uptake: improvement in breast lesion differentiation. J Comput Assist Tomogr 1999;23:615-621.
7. Zhu X, Hawnaur JM, Stringfellow J, Li K-L, Watson Y, Boggis CRM, Jackson A. Quantification of relative blood volume and endothelium permeability of breast neoplasm using dynamic MR imaging. In: Proceedings of the 7th Annual Meeting of ISMRM, Philadelphia, PA, 1999. p 1076.
8. Su MY, Cheung YC, Fruehauf JP, Yu H, Nalcioglu O, Mechetner E, Kyshtoobayeva A, Chen SC, Hsueh S, McLaren CE, Wan YL. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. J Magn Reson Imaging 2003:18:467-477.
9. Brix G, Kiessling F, Lucht R, Darai S, Wasser K, Delorme S, Griebel J. Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series. Magn Reson Med 2004;52:420-429.
10. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17:357-367.
11. Degani H, Gusis V, Weinstein D, Fields S, Strano S. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nat Med 1997;3:780-782.
12. Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, Schild HH. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101-110.
13. Hylton NM. Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging. Magn Reson Imaging Clin N Am 2001;9:321-332, vi.
14. Furman-Haran E, Degani H. Parametric analysis of breast MRI. J Comput Assist Tomogr 2002;26:376-386.
15. Ah-See MW, Padhani AR. Dynamic magnetic resonance imaging in breast cancer. In: Jackson A, Buckley DL, Parker GJM, editors. Dynamic contrast-enhanced magnetic resonance imaging in oncology. Berlin: Springer; 2005. p 145-173.
16. Esserman L, Hylton N, George T, Weidner N. Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J 1999;5:13-21.
17. Bone B, Szabo BK, Perbeck LG, Veress B, Aspelin P. Can contrast-enhanced MR imaging predict survival in breast cancer? Acta Radiol 2003;44:373-378.
18. Hylton NM. Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging. Magn Reson Imaging Clin N Am 1999;7:411-420, x.
19. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaing 1997;7:91-101.
20. Weinmann HJ, Laniado M, Mutzel W. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 1984;16:167-172.
21. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-232.
22. Boos M, Scheffler K, Haselhorst R, Reese E, Frohlich J, Bongartz GM. Arterial first pass gadolinium-CM dynamics as a function of several intravenous saline flush and Gd volumes. J Magn Reson Imaging 2001;13:568-576.
23. Jackson A, Jayson GC, Li KL, Zhu XP, Checkley DR, Tessier JJ, Waterton JC. Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma. Br J Radiol 2003;76:153-162.
24. Bottomley PA, Hardy CJ, Argersinger RE, Allen-Moore G. A review of 1H nuclear magnetic resonance relaxation in pathology: are T1 and T2 diagnostic? Med Phys 1987;14:1-37.
25. Parker GJ, Roberts C, Macdonald A, Buonaccorsi GA, Cheung S, Buckley DL, Jackson A, Watson Y, Davies K, Jayson GC. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 2006;56:993-1000.
26. Li KL, Wilmes LJ, Henry RG, Pallavicini MG, Park JW, Hu-Lowe DD, McShane TM, Shalinsky DR, Fu YJ, Brasch RC, Hylton NM. Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: assessment by voxel analysis of dynamic contrast-enhanced MRI. J Magn Reson Imaging 2005;22:511-519.
27. Zhu XP, Li KL, Kamaly-Asl ID, Checkley DR, Tessier JJ, Waterton JC, Jackson A. Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging. J Magn Reson Imaging 2000;11:575-585.
28. Pickup S, Zhou R, Glickson J. MRI estimation of the arterial input function in mice. Acad Radiol 2003;10:963-968.
29. Li KL, Zhu XP, Jackson A. Parametric mapping of scaled fitting error in dynamic susceptibility contrast enhanced MR perfusion imaging. Br J Radiol 2000;73:470-481.
30. Li KL, Zhu XP, Waterton J, Jackson A. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging 2000;12:347-357.
31. Meng X-L, Rosenthal R, Rubin DB. Comparing correlated correlation coefficients. Psychol Bull 1992;111:172-175.
32. Horsfield MA, Morgan B. Algorithms for calculation of kinetic parameters from T1-weighted dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2004;20:723-729.
33. Jayson GC, Parker GJ, Mullamitha S, Valle JW, Saunders M, Broughton L, Lawrance J, Carrington B, Roberts C, Issa B, Buckley DL, Cheung S, Davies K, Watson Y, Zinkewich-Peotti K, Rolfe L, Jackson A. Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume. J Clin Oncol 2005;23:973-981.
34. Metzler CM. Usefulness of the two-compartment open model in pharmacokinetics. J Am Stat Assoc 1971;66:49-53.
35. Galbraith SM, Lodge MA, Taylor NJ, Rustin GJ, Bentzen S, Stirling JJ, Padhani AR. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semiquantitative analysis. NMR Biomed 2002;15:132-142.
36. Balvay D, Frouin F, Calmon G, Bessoud B, Kahn E, Siauve N, Clement O, Cuenod CA. New criteria for assessing fit quality in dynamic contrast-enhanced T1-weighted MRI for perfusion and permeability imaging. Magn Reson Med 2005;54:868-877.
37. Li KL, Jackson A. New hybrid technique for accurate and reproducible quantitation of dynamic contrast-enhanced MRI data. Magn Reson Med 2003;50:1286-1295.
38. Knopp MV, Weiss E, Sinn HP, Mattern J, Junkermann H, Radeleff J, Magener A, Brix G, Delorme S, Zuna I, van Kaick G. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999;10:260-266.